8-substituted-dibenz [b,f] [1,4] oxazepine-10(11)-carboxylic acid, substituted hydrazides for the treatment of osteoporosis
US5283240A · kind A · utility
20Cited by
13References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 1992 |
| Grant date | Feb 1, 1994 |
| Priority date | — |
| Expiry date | Sep 2, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6527
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a method for treating osteoporosis in a mammal comprising administering to said mammal a therapeutically-effective amount of a compound of Formula I: ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.